Cargando…

Patient-Reported Outcomes and Early Discontinuation in Aromatase Inhibitor-Treated Postmenopausal Women With Early Stage Breast Cancer

BACKGROUND. Early discontinuation of aromatase inhibitors (AIs) is common and leads to poor outcomes but is challenging to predict. In the Exemestane and Letrozole Pharmacogenetics trial, a high rate of early discontinuation due to intolerance was observed. We hypothesized that early changes in pati...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kadakia, Kunal C., Snyder, Claire F., Kidwell, Kelley M., Seewald, Nicholas J., Flockhart, David A., Skaar, Todd C., Desta, Zereunesay, Rae, James M., Otte, Julie L., Carpenter, Janet S., Storniolo, Anna M., Hayes, Daniel F., Stearns, Vered, Henry, N. Lynn
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AlphaMed Press 2016
Materias:	Breast Cancer
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4861358/ https://www.ncbi.nlm.nih.gov/pubmed/27009936 http://dx.doi.org/10.1634/theoncologist.2015-0349

Ejemplares similares

Polymorphisms in drug-metabolizing enzymes and steady-state exemestane concentration in post-menopausal patients with breast cancer
por: Hertz, Daniel L., et al.
Publicado: (2016)

327 Nociplastic pain and early discontinuation of aromatase inhibitor therapy in breast cancer patients over age 65
por: Joyce, Elizabeth, et al.
Publicado: (2022)

Aromatase inhibitor-induced modulation of breast density: clinical and genetic effects
por: Henry, N L, et al.
Publicado: (2013)

Further Evidence That OPG rs2073618 Is Associated With Increased Risk of Musculoskeletal Symptoms in Patients Receiving Aromatase Inhibitors for Early Breast Cancer
por: Hertz, Daniel L., et al.
Publicado: (2021)

Aromatase inhibitor use, side effects and discontinuation rates in gynecologic oncology patients
por: Bell, Sarah G., et al.
Publicado: (2020)

Whole Genome Amplification of DNA for Genotyping Pharmacogenetics Candidate Genes
por: Philips, Santosh, et al.
Publicado: (2012)

Inflammatory cytokines and aromatase inhibitor-associated musculoskeletal syndrome: a case–control study
por: Henry, N L, et al.
Publicado: (2010)

Differences in Time Burden across Local Therapy Strategies for Early-stage Breast Cancer
por: Swanick, Cameron W., et al.
Publicado: (2021)

Real-World Effectiveness of Palbociclib Plus Aromatase Inhibitors in African American Patients With Metastatic Breast Cancer
por: Rugo, Hope S, et al.
Publicado: (2023)

Anatomical Variations of the Pectoralis Muscle and Its Importance for Breast Implant Surgery
por: Montemurro, Paolo, et al.
Publicado: (2023)

DermACELL Acellular Dermal Matrix in Oncologic Breast Reconstruction: A Cohort Study and Systematic Review
por: Swisher, Austin R., et al.
Publicado: (2022)

Early Clinical Outcomes of Polydioxanone Mesh for Prepectoral Prosthetic Breast Reconstruction
por: Qiu, Cecil S., et al.
Publicado: (2022)

Breast Implant-associated Squamous Cell Carcinoma: Initial Review and Early Recommendations
por: Glasberg, Scot B., et al.
Publicado: (2023)

Randomized Controlled Trial of a Home‐Based Walking Program to Reduce Moderate to Severe Aromatase Inhibitor‐Associated Arthralgia in Breast Cancer Survivors
por: Nyrop, Kirsten A., et al.
Publicado: (2017)

Advances in Tissue Expander Technology Enable Early Targeted Intervention in Prepectoral Breast Reconstruction
por: Liu, Farrah, et al.
Publicado: (2021)

Inframammary versus Periareolar Incision: A Comparison of Early Complications in Nipple-sparing Mastectomy
por: Cavalcante, Francisco P., et al.
Publicado: (2023)

Aromatase inhibitor-associated bone and musculoskeletal effects: new evidence defining etiology and strategies for management
por: Gaillard, Stéphanie, et al.
Publicado: (2011)

A Single-center Comparison of Unipedicled and Bipedicled Diep Flap Early Outcomes in 98 Patients
por: Ahmed, Zahra, et al.
Publicado: (2023)

Early Expander-to-Implant Exchange after Postmastectomy Reconstruction Reduces Rates of Subsequent Major Infectious Complications
por: Schwartz, Jean-Claude D.
Publicado: (2020)

Early versus Delayed Implant Exchange after Periprosthetic Breast Infection: A Single Center Study
por: Falola, Reuben A., et al.
Publicado: (2021)

Closed Incisional Negative Pressure Therapy Significantly Reduces Early Wound Dehiscence after Reduction Mammaplasty
por: Johnson, Owen N., et al.
Publicado: (2021)

Long-Term Outcome of Neoadjuvant Endocrine Therapy with Aromatase Inhibitors in Elderly Women with Hormone Receptor-Positive Breast Cancer
por: Grassadonia, Antonino, et al.
Publicado: (2014)

Health‐Related Quality of Life in MONARCH 3: Abemaciclib plus an Aromatase Inhibitor as Initial Therapy in HR+, HER2− Advanced Breast Cancer
por: Goetz, Matthew P., et al.
Publicado: (2020)

Impact of body mass index on estradiol depletion by aromatase inhibitors in postmenopausal women with early breast cancer
por: Pfeiler, G, et al.
Publicado: (2013)

Clinical Utility of Aromatase Inhibitors as Adjuvant Treatment in Postmenopausal Early Breast Cancer
por: Loaiza-Bonilla, Arturo, et al.
Publicado: (2013)

Does digital mammography suppose an advance in early diagnosis? Trends in performance indicators 6 years after digitalization
por: Sala, Maria, et al.
Publicado: (2014)

Pyoderma Gangrenosum after Breast Cancer Resection: A Less-invasive and Early Treatment Using the Skin around Ulcers
por: Hirai, Kotaro, et al.
Publicado: (2022)

Percutaneous Sonazoid-enhanced ultrasonography combined with in vitro verification for detection and characterization of sentinel lymph nodes in early breast cancer
por: Hao, Yunxia, et al.
Publicado: (2021)

Early Postoperative Complications From National Surgical Quality Improvement Program: A Closer Examination of Timing and Technique of Breast Reconstruction
por: Saheb-Al-Zamani, Maryam, et al.
Publicado: (2021)

High concordance of 70‐gene recurrence risk signature and 80‐gene molecular subtyping signature between core needle biopsy and surgical resection specimens in early‐stage breast cancer
por: Crozier, Jennifer A., et al.
Publicado: (2021)

Aromatase inhibitors, efficacy and metabolic risk in the treatment of postmenopausal women with early breast cancer
por: Gonnelli, Stefano, et al.
Publicado: (2008)

Prevention, Diagnosis, and Management of Upper Extremity Lymphedema Complications: Altmetric Analysis of Online Media
por: Kirloskar, Kunal M., et al.
Publicado: (2022)

CYP2D6 genotype and tamoxifen response
por: Rae, James M, et al.
Publicado: (2005)

Assessment of early treatment response to neoadjuvant chemotherapy in breast cancer using non-mono-exponential diffusion models: a feasibility study comparing the baseline and mid-treatment MRI examinations
por: Bedair, Reem, et al.
Publicado: (2016)

An Advanced Surgical Dressing for High-risk Patients Undergoing Breast Cancer Surgery: A Case-control Study
por: Nicotera, A., et al.
Publicado: (2021)

Preventing Infection in Implant-based Breast Reconstruction: Evaluating the Evidence for Common Practices and Standardized Protocols
por: Baker, Nusaiba F., et al.
Publicado: (2022)

Quality of life and psychological functioning in postmenopausal women undergoing aromatase inhibitor treatment for early breast cancer
por: Martino, Gabriella, et al.
Publicado: (2020)

Incidence and Outcomes of Completion Mastectomy following Oncoplastic Reduction: A Case Series
por: Baker, Nusaiba F., et al.
Publicado: (2022)

Drain Removal Time in Pre-pectoral versus Dual Plane Prosthetic Breast Reconstruction following Nipple-sparing Mastectomy
por: Moriarty, Hannah K., et al.
Publicado: (2022)

Lack of association between oestrogen receptor polymorphisms and change in bone mineral density with tamoxifen therapy
por: Henry, N L, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_tad7mfkrtgeqck52hflfmm5ckb